Nitrofurantoin – Oral Products
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 26, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news

nitrofurantoin
Title: nitrofurantoinCategory: MedicationsCreated: 3/26/1998 12:00:00 AMLast Editorial Review: 8/20/2022 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - August 20, 2022 Category: Drugs & Pharmacology Source Type: news

Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCT
RCT (n=240) found methenamine is not inferior to current standard care (daily 50/100mg nitrofurantoin, 100mg trimethoprim or 250mg cefalexin) in preventing recurrent UTI ' s. Results suggest antimicrobial resistance is proportionally higher in women taking prophylactic antibiotics. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 11, 2022 Category: Consumer Health News Source Type: news

Alembic Pharma gets USFDA nod for generic Nitrofurantoin capsules
According to IQVIA, Nitrofurantoin capsules, USP (Macrocrystals), 25 mg, 50 mg and 100 mg have an estimated market size of USD 23 million for the twelve months ending March 2021, Alembic Pharma said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 1, 2021 Category: Pharmaceuticals Source Type: news

Antibiotic Prescribing Choices and Their Comparative C. Difficile Infection Risks: A Longitudinal Case-Cohort Study, Clinical Infectious Diseases 72(5): 836-844
Conclusions C. difficile infection risk increases with antibiotic duration, and there are wide disparities in risks associated with antibiotic courses used for similar indications. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - March 17, 2021 Category: Consumer Health News Source Type: news

Class 2 Medicines Recall: Nitrofurantoin 50 mg Tablets, PL
Dr Reddy’s Laboratories (UK) Limited is recalling all unexpired stock of a specific batch of Nitrofurantoin 50mg Tablets from pharmacies and wholesalers as a precautionary measure due to out of (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 15, 2020 Category: Drugs & Pharmacology Source Type: news

GlaxoSmithKline announces start of phase III trial of gepotidacin in treatment of uncomplicated urinary tract infection (UTI) and urogenital gonorrhoea
Gepotidacin is first in new chemical class of antibiotics called triazaacenaphthylene bacterial topoisomerase inhibitors. Development programme comprises two separate studies, EAGLE-1 (vs. ceftriaxone + azithromycin in gonorrhoea) and EAGLE-2 (vs. nitrofurantoin for UTI). (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - October 30, 2019 Category: Consumer Health News Source Type: news

Macrobid (Nitrofurantoin) Side Effects
Title: Macrobid (Nitrofurantoin) Side EffectsCategory: MedicationsCreated: 10/18/2019 12:00:00 AMLast Editorial Review: 10/18/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - October 18, 2019 Category: Drugs & Pharmacology Source Type: news

Investigation points to possible urinary tract infection drug market carve-up
CMA provisionally implicates two suppliers and a wholesaler of antibiotic Nitrofurantoin Related items fromOnMedica NI launches ‘One Health’ plan to tackle antimicrobial resistance Clinicians need better options if we are to stop over-medication Doctors urge government to act on rising alcohol impact Finding new cures with data transparency CQC finds safety concerns with online primary care (Source: OnMedica Latest News)
Source: OnMedica Latest News - July 28, 2019 Category: UK Health Source Type: news

Nitrofurantoin vs. Bactrim
Title: Nitrofurantoin vs. BactrimCategory: MedicationsCreated: 6/28/2019 12:00:00 AMLast Editorial Review: 6/28/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - June 28, 2019 Category: Drugs & Pharmacology Source Type: news